JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C Mutation

PHASE3RecruitingINTERVENTIONAL
Enrollment

392

Participants

Timeline

Start Date

August 7, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

February 28, 2027

Conditions
Advanced Non-squamous Non-small-cell Lung CancerMetastatic Non-squamous Non Small Cell Lung Cancer
Interventions
DRUG

JAB-21822

JAB-21822 administered orally as a tablet

DRUG

Tislelizumab

Tislelizumab administered as an intravenous (IV) infusion

DRUG

JAB-3312

JAB-3312 administered orally as a tablet or capsule

DRUG

Pemetrexed

Pemetrexed administered as an intravenous (IV) infusion

DRUG

Carboplatin

Carboplatin administered as an intravenous (IV) infusion

Trial Locations (37)

100005

NOT_YET_RECRUITING

Pecking Union Medical College Hospital, Beijing

100021

RECRUITING

Cancer Hospital Chinese Academy Of Medical Sciences, Beijing

100070

NOT_YET_RECRUITING

Beijing Tiantan Hospital, Captal Medical University, Beijing

100142

RECRUITING

Beijing Cancer Hospital, Beijing

100191

RECRUITING

Peking University Third Hospital, Beijing

101125

RECRUITING

Beijing Chest Hospital ,Capital Medical University, Beijing

110001

NOT_YET_RECRUITING

The First Hospital Of China Medical University, Shenyang

110801

NOT_YET_RECRUITING

Liaoning Cancer Hospital & Institute, Shenyang

130021

NOT_YET_RECRUITING

Jilin cancer hospital, Jilin

150081

NOT_YET_RECRUITING

Harbin Medical University Cancer Hospital-Mammary gland of internal, Haerbin

200032

NOT_YET_RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

200433

NOT_YET_RECRUITING

Shanghai Pulmonary Hospital, Shanghai

210029

NOT_YET_RECRUITING

Jiangsu province hospital, Nanjing

214023

NOT_YET_RECRUITING

Wuxi People's Hospital, Wuxi

230031

NOT_YET_RECRUITING

Anhui Province cancer hospital, Hefei

250012

RECRUITING

Shandong Cancer Hospital, Jinan

266003

NOT_YET_RECRUITING

The affiliated hospital of Qingdao university, Qingdao

276002

NOT_YET_RECRUITING

LinYi Cancer Hospital, Linyi

300181

NOT_YET_RECRUITING

Tianjin Medical University Cancer Institute Hospital, Tianjin

310003

NOT_YET_RECRUITING

The First affiliated hospital Zhejiang university school of medicine, Hangzhou

NOT_YET_RECRUITING

The Second Affiliated Hospital Zhejiang School of Medicine, Hangzhou

317000

NOT_YET_RECRUITING

Taizhou Hospital Zhejiang Province, Taizhou

350014

NOT_YET_RECRUITING

Fujian cancer Hospital, Fuzhou

410031

NOT_YET_RECRUITING

Hunan Cancer Hospital, Changsha

430022

NOT_YET_RECRUITING

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

430030

NOT_YET_RECRUITING

Tongji Hospital Tongji Medical College of Hust, Wuhan

430079

NOT_YET_RECRUITING

Hubei cancer hospital, Wuhan

450003

NOT_YET_RECRUITING

Henan Cancer Hospital, Zhengzhou

450052

NOT_YET_RECRUITING

The First Affiliated Hosipital Of Zhengzhou University, Zhengzhou

510080

NOT_YET_RECRUITING

The first Affiliated Hospital, Sun Yat-sen University, Guangzhou

518116

NOT_YET_RECRUITING

Cancer Hospital Chinese Academy Of medical Sciences Shenzhen Center, Shenzhen

530000

NOT_YET_RECRUITING

Guangxi Medical University Cancer hospital & Guangxi Cancer Institute, Nanning

610041

NOT_YET_RECRUITING

Sichuan province cancer hospital, Chengdu

610044

NOT_YET_RECRUITING

West China Hospital Sichuan University, Chengdu

710061

NOT_YET_RECRUITING

The First Affiliated Hospital of Xi'An Jiaotong University, Xi’an

061000

RECRUITING

Cangzhou hospital of integrated TCM-WM Hebei, Cangzhou

030013

NOT_YET_RECRUITING

Shanxi province cancer hospital, Taiyuan

Sponsors
All Listed Sponsors
lead

Allist Pharmaceuticals, Inc.

INDUSTRY